New treatment options for generalized myasthenia gravis

Myasthenia gravis is an autoimmune disease in which autoantibodies against the postsynaptic membrane proteins of the neuromuscular junction disrupt impulse transmission thus causing pathological muscle weakness and fatigue that worsens throughout the day. Although the disease is not yet curable, mos...

Full description

Saved in:
Bibliographic Details
Main Authors: Antanas Vaitkus, J. Čiauškaitė, M. Malakauskaitė, M. Baublytė
Format: Article
Language:English
Published: Vilnius University Press 2024-02-01
Series:Neurologijos seminarai
Subjects:
Online Access:https://www.journals.vu.lt/neurologijos_seminarai/article/view/34581
Tags: Add Tag
No Tags, Be the first to tag this record!